| Model Number |
GELWEAVE BIFURCATE |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Codes |
Renal Failure (2041); Ruptured Aneurysm (4436); Thrombosis/Thrombus (4440)
|
| Date of Event |
09/12/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
(b)(4).A review of qc, manufacturing and physical test records was carried out and show the batch was manufactured to design specification and met all in process and bass material physical test acceptance criteria.Historical data analysis - a 5-year similar event review was performed on thrombus/occlusion events related to gelweave product - this gave an occurrence rate of 0.003% (complaints v sales) device not accessible for testing - the device was explanted, but its disposition is unknown.(b)(4).Considers this event as closed.
|
| |
|
Event or Problem Description
|
|
Patient was implanted with a gelweave bifurcate device on (b)(6) 2020.The following day, the clinician confirmed thrombosis post-op.The patient showed low levels of blood pressure.Patient suffered hypovolemic shock due to aaa rupture and acute renal failure which resulted in patient death.Clinician confirmed that the event is not related to a device failure and that it was related to a patient pre-existing condition.
|
| |
|
Search Alerts/Recalls
|